New Affordable Nanobiocomposite with Useful Biomedical Properties

A group of researchers recently published a paper in the journal Scientific Reports that demonstrated the feasibility of using a novel graphene oxide-folic acid/silk fibroin (GO-FA/SF) nanobiocomposite in biomedical applications.

New Affordable Nanobiocomposite with Useful Biomedical Properties​​​​​​​


Study: Functionalized graphene oxide nanosheets with folic acid and silk fibroin as a novel nanobiocomposite for biomedical applications. Image Credit: Buravleva stock/

Importance of GO, FA, and SF for the Synthesis of Novel Nanobiomaterial

Graphene, a two-dimensional (2D) layered structure of carbon atoms, has gained considerable prominence owing to its exceptional chemical properties. Graphene analogs, such as GO and graphene nanosheets, are typically produced by functionalizing and modifying the carbon platform of graphene.

GO can be obtained through the Hummers method, where strong oxidizing agents such as concentrated sulfuric acid and potassium permanganate react with graphite to produce GO in the form of a yellow colloidal dispersion.

GO and its derivatives are suitable for different applications, such as skin-tissue and bone engineering and pH-dependent drug delivery. This is because of its unique properties, such as inhibition of bacterial growth, aqueous processability, and ability to synthesize stable colloidal suspensions.

The conductivity, tensile strength, and elasticity of GO can be further improved by combining it with natural or synthetic materials such as vitamins and polymers. FA, a water-soluble vitamin, is often used in biomaterials with potential bioapplications such as drug carriers and imaging systems due to its non-toxicity, biocompatibility, and low cost.

By functionalizing GO with FA through covalent bonds via the amidation process, biocompatible materials with an extensive range of bioapplications can be synthesized effectively.

SF, a well-known natural protein found in silkworms, has gained prominence as a potential candidate for scaffolds in tissue engineering and biomaterials owing to its significant biodegradability, biocompatibility, elasticity, and mechanical strength. Additionally, silk can be easily purified and isolated and has a low risk of infection. The GO-FA conjugate can be blended with SF through the freeze-drying process to fabricate a novel nanobiocomposite.

Nanobiomaterials have demonstrated significant potential in different applications such as pharmacology and nanomedicine. Although nanobiomaterials possess several advantages, they can cause biological side-effects such as an inflammatory reaction, which can eventually lead to cell death. Thus, the interactions and toxicity of these nanobiomaterials on the biological systems must be considered and evaluated before utilizing them in biological applications.

Synthesis of GO-FA/SF Nanobiocomposite

In this study, researchers synthesized a biocompatible and non-toxic novel GO-FA/SF nanobiocomposite and evaluated the feasibility of using the synthesized sample in bioapplications.

GO was synthesized from graphite flake through the modified Hummer method. 0.3 grams of 4-(dimethylamino) pyridine (DMAP) and 1.85 grams of N, N′-dicyclohexylcarbodiimide (DCC) were added to 0.5 grams of GO suspension in 100 milliliters of dimethyl sulfoxide (DMSO), and the resultant mixture was sonicated for 20 minutes to activate the terminal carboxyl and carbonyl groups of GO.

Subsequently, 0.3 grams of FA was mixed with the activated GO, and the mixture was again sonicated for 20 minutes and stirred overnight. The mixture was then centrifuged and washed with distilled water and ethanol to eliminate DSMO and nonconjugated FAs from the GO-FA. Eventually, the GO-FA mixture was washed using acetone and dried at room temperature to obtain GO-FA in a powder form.

SF was extracted from cocoons through degumming, rehydration, and dialysis steps. For a few minutes, 0.2 grams of GO-FA was sonicated in distilled water and then mixed with 5 milliliters of SF solution, and the mixture was kept under stirring conditions for four hours. Subsequently, the resultant suspension mixture was placed in a petri dish for the freeze-drying process. The sample was initially kept in a freezer at -70 degree Celsius for 24 hours and then in a freeze-dryer device for 24 hours to sublimate the solvent, followed by the dehydration process at -60 degree Celsius to obtain the GO-FA/SF nanobiocomposite.

Characterization and Evaluation of Synthesized Samples

Fourier-transform infrared (FT-IR) spectroscopy, field emission-scanning electron microscopy (FE-SEM), X-ray diffraction (XRD) method, and thermogravimetric analysis (TGA) were used to characterize the synthesized samples. Researchers also performed anti-biofilm, 3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT), and hemolysis assays on Pseudomonas aeruginosa (P. aeruginosa), human skin fibroblast (Hu02) cells, and human red blood cells (RBCs), respectively, to evaluate the biological capability of the synthesized nanobiocomposite.          

Research Findings

A novel GO-FA/SF nanobiocomposite was fabricated successfully using inexpensive and non-toxic starting materials. The FT-IR analysis confirmed the presence of hydroxyl, carboxyl, alcohol, alkoxy, and epoxy groups, as well as an unoxidized graphitic domain in the synthetic GO. Additionally, the analysis also confirmed the formation of an amide bond during the conjugation of FA with GO, and the presence of SF in the nanobiocomposite.

The modified GO in the GO-FA/SF nanobiocomposite demonstrated smooth unilamellar morphology while preserving the characteristic structure of the pure GO flakes. The GO-FA/SF degraded gradually with increasing temperatures, with the complete decomposition of the nanobiocomposite observed at 800 degrees Celsius.

The biological assays displayed exceptional features of the GO-FA/SF nanobiocomposite. The cell viability percentages were 97.23, 96.35, and 96.67% when Hu02 cells were treated with the synthesized nanobiocomposite for 72, 48, and 24 hours, respectively, and the cells maintained their fibroblast shape, indicating the non-toxicity and biocompatibility of the GO-FA/SF nanobiocomposite.

The hemolysis percentages for 72 and 24 hours of extraction time were less than 10%, which demonstrated the hemocompatibility of the synthesized nanobiocomposite. Moreover, the synthesized GO-FA/SF nanobiocomposite effectively inhibited the formation of P. aeruginosa biofilm on its surface.

Taken together, the findings of this study demonstrated that the synthesized GO-FA/SF nanobiocomposite can be used safely and effectively for different biomedical applications such as tissue engineering and wound healing.


Mahdavi, M., Madanchi, H., Maleki, A. et al. (2022) Functionalized graphene oxide nanosheets with folic acid and silk fibroin as a novel nanobiocomposite for biomedical applications. Scientific Reports.

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

Samudrapom Dam

Written by

Samudrapom Dam

Samudrapom Dam is a freelance scientific and business writer based in Kolkata, India. He has been writing articles related to business and scientific topics for more than one and a half years. He has extensive experience in writing about advanced technologies, information technology, machinery, metals and metal products, clean technologies, finance and banking, automotive, household products, and the aerospace industry. He is passionate about the latest developments in advanced technologies, the ways these developments can be implemented in a real-world situation, and how these developments can positively impact common people.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dam, Samudrapom. (2022, April 19). New Affordable Nanobiocomposite with Useful Biomedical Properties. AZoNano. Retrieved on June 25, 2022 from

  • MLA

    Dam, Samudrapom. "New Affordable Nanobiocomposite with Useful Biomedical Properties". AZoNano. 25 June 2022. <>.

  • Chicago

    Dam, Samudrapom. "New Affordable Nanobiocomposite with Useful Biomedical Properties". AZoNano. (accessed June 25, 2022).

  • Harvard

    Dam, Samudrapom. 2022. New Affordable Nanobiocomposite with Useful Biomedical Properties. AZoNano, viewed 25 June 2022,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type